Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Açın
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1.091,51
-2,30
-0,21%
—1.093,811.096,521.100,221.091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1.237,98
-16,83
-1,34%
—1.254,811.253,011.253,871.226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1.744,71
-16,40
-0,93%
—1.761,111.764,271.766,881.744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3.260,69
+48,86
+1,52%
—3.211,833.227,213.268,383.226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1.466,80
-7,72
-0,52%
—1.474,521.479,031.481,041.466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2.397,50
+5,38
+0,22%
—2.392,122.396,952.421,222.382,32——
87S:FRA
Roivant Sciences Ltd
23,54 €
0,00%
(0,00) 1D
30 apr, 15:25:02 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 87S...
Mkt. cap
19,92 mlrd
Avg. vol.
6,00
Volume
0,00
52-wk high
25,72 €
52-wk low
8,98 €
No. of employees
750
News stories
From sources across the web
Profile
Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel. Wikipedia
About Roivant Sciences Ltd
CEOMatt Gline
Employees750
Founded7 apr 2014
Headquarters-
Sector-
Websiteroivant.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
mar 2025
iyn 2025
sen 2025
dek 2025
Revenue
7,57 mln
2,17 mln
1,57 mln
2,00 mln
Cost of goods sold
145,04 mln
152,57 mln
164,18 mln
166,08 mln
Cost of revenue
145,04 mln
152,57 mln
164,18 mln
166,08 mln
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
227,69 mln
128,22 mln
129,52 mln
175,05 mln
Operating expense
227,69 mln
128,22 mln
129,52 mln
175,05 mln
Total operating expenses
372,74 mln
280,79 mln
293,70 mln
341,13 mln
Operating income
-365,16 mln
-278,62 mln
-292,13 mln
-339,14 mln
Other non operating income
11,28 mln
-13,54 mln
-26,65 mln
-16,07 mln
EBT including unusual items
-203,05 mln
-269,26 mln
-159,04 mln
-290,37 mln
EBT excluding unusual items
-299,26 mln
-243,84 mln
-273,44 mln
-311,94 mln
Income tax expense
49,32 mln
4,65 mln
7,00 mln
23,33 mln
Effective tax rate
-24,29%
-1,73%
-4,40%
-8,04%
Other operating expenses
-
-
-
-
Net income
-206,48 mln
-223,36 mln
-113,52 mln
-265,89 mln
Net profit margin
-2.727,54%
-10.292,86%
-7.225,91%
-13.301,20%
Earnings per share
-0,22
-0,25
-0,28
-0,24
Interest and investment income
54,62 mln
48,32 mln
45,34 mln
43,27 mln
Interest expense
-
-
-
-
Net interest expenses
54,62 mln
48,32 mln
45,34 mln
43,27 mln
Depreciation and amortization charges
-
-
-
-
EBITDA
-357,00 mln
-277,52 mln
-291,21 mln
-338,44 mln
Gain or loss from assets sale
-3,11 mln
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer